Atlas Venture Fund X, L.P. Magenta Therapeutics, Inc. (MGTA) insider trading activity

Atlas Venture Fund X, L.P. is > 10% Shareholder of Magenta Therapeutics, Inc.. Currently has a direct ownership of 3.15 Million shares of MGTA, which is worth approximately $0. The most recent transaction as insider was on Feb 11, 2021, when has been sold 968,726 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.15M

0% 3M change

0% 12M change

Total Value Held $0

Atlas Venture Fund X, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Feb 11 2021	SELL Other acquisition or disposition	-	968,726 Reduced 23.53%	3,148,399 Common Stock

Also insider at

GBIO

Generation Bio Co. Healthcare

> 10% Shareholder

KYMR

Kymera Therapeutics, Inc. Healthcare

IKNA

Ikena Oncology, Inc. Healthcare

> 10% Shareholder

GMTX

Gemini Therapeutics, Inc. Healthcare

> 10% Shareholder

AVF